Cannabis
Latest news and updates related to cannabis
About Cannabis coverage
The Cannabis news hub on Global Investing News tracks 19 recent headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Cannabis developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Cannabis across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Cannabis headlines
Market Data
(5)The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Tilray CEO on Possible US Cannabis Reclassification
Tilray CEO on Possible US Cannabis Reclassification
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
Tilray and other cannabis stocks soar as Trump is reportedly ready to reclassify the substance
Cannabis CEO Calls for Reform
Cannabis CEO Calls for Reform
Will Thailand Recriminalize Cannabis?
Thailand's potential pivot toward recriminalizing cannabis marks a significant regulatory reversal that threatens to disrupt a domestic industry estimated to be worth $1.2 billion annually. Since becoming the first Southeast Asian nation to decriminalize the plant in 2022, the lack of robust secondary legislation led to a 'gray market' explosion, with over 20,000 dispensaries opening nationwide. Prime Minister Srettha Thavisin’s administration is now signaling a move to restrict usage to medical and health purposes only, citing concerns over social impact and youth consumption. For investors, this creates substantial sovereign and regulatory risk. The move could disenfranchise thousands of small businesses and deter international venture capital that had begun flowing into Thai-based cultivation and extraction facilities. From a competitive standpoint, this backtrack may cede the regional first-mover advantage to other jurisdictions eyeing controlled legalization. Sophisticated investors should monitor the specific language of the upcoming bill, specifically whether 'medical use' will be defined broadly enough to allow existing retail infrastructure to pivot, or if it will be strictly confined to hospital-grade pharmaceutical distribution. The outcome will serve as a bellwether for how other emerging markets balance economic liberalization with conservative social governance.
Other Sources
(5)This cannabis ETF outperformed the S&P in 2025: Outlook for 2026
Reportedly, a cannabis exchange-traded fund (ETF) surpassed the performance of the S&P 500 in 2025, signaling a potentially strong year for the sector. The article will likely delve into the factors contributing to this outperformance and provide an outlook for continued growth or challenges in the cannabis market for 2026, considering evolving regulations and market dynamics.
After Trump’s move to reclassify cannabis, here’s what Wall Street is thinking
This headline refers to former President Trump's administration's potential reclassification of cannabis under federal law. Such a move, likely from Schedule I to Schedule III under the Controlled Substances Act, would significantly reduce the regulatory burden on cannabis businesses, potentially opening up new avenues for banking, research, and corporate investment in the burgeoning industry.
Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling
Tilray Brands experienced a significant stock surge on December 18th following news that former President Trump has tasked officials with reviewing marijuana's scheduling. This development signals potential progress toward decriminalization or legalization at the federal level, which would open up new market opportunities for cannabis companies like Tilray.
Micron soars, cannabis stocks pop on Trump's executive order
Micron Technology (MU) shares surged following positive analyst commentary and strong demand forecasts for memory chips. Concurrently, cannabis stocks experienced a significant uplift after President Trump issued an executive order, signaling a potential shift in federal policy towards the industry, specifically mentioning relief for cannabis-related banking issues.
Trump signs executive order reclassifying pot, opening door to broader access
Former President Trump signed an executive order regarding the reclassification of cannabis, signaling a potential shift towards broader access and less restrictive federal policies. This move could lead to significant changes for the cannabis industry, including easier research, banking, and interstate commerce, potentially unlocking new markets and investment opportunities.
Get alerts for this topic
Subscribe to receive updates about "Cannabis"